{
 "url": "https://etfiq.com/funds/canc/holdings/",
 "section": "funds",
 "title": "CANC Holdings: All 57 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 57 CANC holdings with weights, as of Oct 13, 2026. The top 3 are RVMD 5.63%, MRK 5.44% and LLY 4.85%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "CANC",
 "fund": "Tema Oncology ETF",
 "fund_page": "https://etfiq.com/funds/canc",
 "positions": 57,
 "positions_listed_on_page": 57,
 "lead": "CANC held 57 positions as of Oct 13, 2026. Revolution Medicines Inc is the largest at 5.63%; the top 10 are 41.9% of the fund.",
 "source": {
  "name": "Tema",
  "url": "https://temaetfs.com/hubfs/Website/Holdings/CANC-holdings-10132026.csv",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Revolution Medicines Inc",
   "ticker": "RVMD",
   "weight_pct": 5.63,
   "page": "https://etfiq.com/holdings/rvmd/"
  },
  {
   "rank": 2,
   "holding": "Merck & Co Inc",
   "ticker": "MRK",
   "weight_pct": 5.44,
   "page": "https://etfiq.com/holdings/mrk/"
  },
  {
   "rank": 3,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 4.85,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 4,
   "holding": "Cogent Biosciences Inc",
   "ticker": "COGT",
   "weight_pct": 4.38,
   "page": "https://etfiq.com/holdings/cogt/"
  },
  {
   "rank": 5,
   "holding": "Novartis AG",
   "ticker": "NOVN",
   "weight_pct": 3.98,
   "page": "https://etfiq.com/holdings/novn/"
  },
  {
   "rank": 6,
   "holding": "Genmab A/S (ADR)",
   "ticker": "GMAB",
   "weight_pct": 3.76,
   "page": "https://etfiq.com/holdings/gmab/"
  },
  {
   "rank": 7,
   "holding": "BeOne Medicines Ltd",
   "ticker": "ONC",
   "weight_pct": 3.53,
   "page": "https://etfiq.com/holdings/onc/"
  },
  {
   "rank": 8,
   "holding": "AbbVie Inc",
   "ticker": "ABBV",
   "weight_pct": 3.51,
   "page": "https://etfiq.com/holdings/abbv/"
  },
  {
   "rank": 9,
   "holding": "Halozyme Therapeutics Inc",
   "ticker": "HALO",
   "weight_pct": 3.45,
   "page": "https://etfiq.com/holdings/halo/"
  },
  {
   "rank": 10,
   "holding": "Exelixis Inc",
   "ticker": "EXEL",
   "weight_pct": 3.41,
   "page": "https://etfiq.com/holdings/exel/"
  },
  {
   "rank": 11,
   "holding": "Iovance Biotherapeutics Inc",
   "ticker": "IOVA",
   "weight_pct": 3.36,
   "page": "https://etfiq.com/holdings/iova/"
  },
  {
   "rank": 12,
   "holding": "Roche Holding AG",
   "ticker": "RHHBY",
   "weight_pct": 2.81,
   "page": null
  },
  {
   "rank": 13,
   "holding": "Bridgebio Pharma Inc",
   "ticker": "BBIO",
   "weight_pct": 2.74,
   "page": "https://etfiq.com/holdings/bbio/"
  },
  {
   "rank": 14,
   "holding": "Bristol-Myers Squibb Co",
   "ticker": "BMY",
   "weight_pct": 2.68,
   "page": "https://etfiq.com/holdings/bmy/"
  },
  {
   "rank": 15,
   "holding": "Ideaya Biosciences Inc",
   "ticker": "IDYA",
   "weight_pct": 2.49,
   "page": "https://etfiq.com/holdings/idya/"
  },
  {
   "rank": 16,
   "holding": "CG oncology Inc",
   "ticker": "CGON",
   "weight_pct": 2.47,
   "page": "https://etfiq.com/holdings/cgon/"
  },
  {
   "rank": 17,
   "holding": "Enliven Therapeutics Inc",
   "ticker": "ELVN",
   "weight_pct": 2.29,
   "page": null
  },
  {
   "rank": 18,
   "holding": "Immunome Inc",
   "ticker": "IMNM",
   "weight_pct": 2.28,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Astrazeneca PLC",
   "ticker": "AZN",
   "weight_pct": 2.18,
   "page": "https://etfiq.com/holdings/azn/"
  },
  {
   "rank": 20,
   "holding": "Johnson & Johnson",
   "ticker": "JNJ",
   "weight_pct": 2.14,
   "page": "https://etfiq.com/holdings/jnj/"
  },
  {
   "rank": 21,
   "holding": "Erasca Inc",
   "ticker": "ERAS",
   "weight_pct": 2.0,
   "page": "https://etfiq.com/holdings/eras/"
  },
  {
   "rank": 22,
   "holding": "Legend Biotech Corp",
   "ticker": "LEGN",
   "weight_pct": 1.94,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Relay Therapeutics Inc",
   "ticker": "RLAY",
   "weight_pct": 1.94,
   "page": "https://etfiq.com/holdings/rlay/"
  },
  {
   "rank": 24,
   "holding": "Zai Lab Ltd",
   "ticker": "ZLAB",
   "weight_pct": 1.74,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Summit Therapeutics Inc",
   "ticker": "SMMT",
   "weight_pct": 1.62,
   "page": null
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 1.61
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/canc/holdings/canc-holdings.csv",
 "json_book": "https://etfiq.com/data/books/canc.json",
 "markdown": "https://etfiq.com/funds/canc/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of CANC, data as of Oct 13, 2026. https://etfiq.com/funds/canc/holdings/"
}